Researchers Call for State-Led Medical Marijuana Research Centers Following Federal Rescheduling

Medical marijuana is legally available to patients across much of the United States, but researchers still have many unanswered questions about how marijuana should be used in medicine.

Now, researchers are calling on states to help change that. A recent commentary published in Clinical Therapeutics argues that states should establish dedicated medical marijuana research centers following significant changes in federal marijuana policy.

These centers could study how patients use marijuana in real-world medical marijuana programs and help answer questions about effectiveness, dosing, safety, product formulations, and long-term outcomes.

For Virginia, additional research could be particularly valuable because practitioners have significant discretion when determining whether a patient's condition may benefit from medical marijuana.

Researchers Want States to Invest in Medical Marijuana Research

For decades, marijuana research in the United States has faced an unusual challenge.

States increasingly legalized marijuana for medical purposes while marijuana remained a Schedule I controlled substance under federal law.

That classification created substantial regulatory barriers for researchers. As a result, patients gained access to an expanding variety of marijuana products while the amount of high-quality clinical evidence available to healthcare practitioners developed much more slowly.

Researchers now believe changing federal marijuana policy creates an opportunity to address that problem.

Their proposal is for states to develop dedicated research infrastructure focused specifically on medical marijuana.

Why Has Medical Marijuana Research Lagged Behind?

Under federal law, Schedule I substances face some of the strictest controls. Researchers seeking to study marijuana historically had to navigate extensive regulatory requirements. Researchers were also limited in their ability to study the same types of marijuana products patients might encounter in state-regulated markets.

Meanwhile, medical marijuana products became increasingly diverse. Patients today may encounter products containing different concentrations and ratios of THC, CBD, and other cannabinoids.

Products can also differ significantly in their formulation and method of administration.

Without sufficient research, practitioners may have limited clinical evidence when attempting to answer highly specific patient questions about those products.

How Could Federal Rescheduling Change Marijuana Research?

Changes to marijuana's federal scheduling could make it easier for researchers to conduct certain types of marijuana studies.

Reducing the federal restrictions associated with marijuana could potentially encourage universities, hospitals, pharmaceutical researchers, and other institutions to pursue studies that were previously difficult to conduct.

It could also make funding and institutional participation in marijuana research more practical. However, researchers argue that federal policy changes are only the beginning.

States already have functioning medical marijuana systems that could provide unique research opportunities.

What Would State-Led Research Centers Do?

Dedicated medical marijuana research centers could coordinate studies involving researchers, universities, healthcare professionals, state agencies, and medical marijuana patients.

Potential areas of research could include:

• Which conditions and symptoms may respond to marijuana

• Appropriate THC and CBD concentrations

• Effective dosing strategies

• Differences between methods of administration

• Potential interactions with prescription medications

• Short-term and long-term side effects

• Effects on patient quality of life

• Differences in outcomes among patient populations

• Patterns of marijuana use

• Patient experiences with different products

• Whether marijuana affects patients' use of other medications

Researchers could also use findings from real-world patients to identify questions that deserve more rigorous clinical trials.

Why This Matters in Virginia

Virginia's medical marijuana program differs from programs in some other states.

Rather than limiting medical marijuana eligibility to a narrow statutory list of qualifying conditions, Virginia allows an eligible practitioner to issue a written certification when the practitioner determines that a patient's condition or disease may benefit from marijuana products.

This gives practitioners greater flexibility when evaluating patients. It also makes strong medical research especially valuable.

Practitioners must use their professional judgment to determine whether medical marijuana may be appropriate for an individual patient. More research could give Virginia practitioners additional evidence to consider when making those decisions.

Research Could Help Practitioners Make More Individualized Recommendations

Marijuana is not a single uniform product. THC and CBD can have different effects, and products may contain different concentrations of each cannabinoid.

Patients can also respond differently depending on factors such as age, medical history, medications, marijuana experience, and the symptoms they are trying to address. Expanded research could help practitioners better understand these differences.

For example, future studies could examine whether certain cannabinoid profiles are associated with better outcomes for particular symptoms or whether some methods of administration are more appropriate for certain patients. That type of evidence could make medical marijuana discussions increasingly individualized.

Virginia's Medical Marijuana Program Offers Real-World Research Opportunities

Virginia has an established medical marijuana program overseen by the Virginia marijuana Control Authority. Patients who receive valid written certifications from eligible practitioners can access medical marijuana through the state's regulated system.

Those patients represent a potential source of real-world information about medical marijuana use. With appropriate research protocols and patient protections, researchers could potentially study trends in patient outcomes, product selection, dosing, adverse effects, and other factors.

This information could complement traditional clinical trials.

Why Real-World Marijuana Products Matter

One challenge with historical marijuana research has been the difference between marijuana studied in federally authorized settings and products available through state medical marijuana programs.

State-regulated products can vary considerably in potency, cannabinoid profile, and formulation.

If researchers can study products that more closely reflect what patients actually use, the results may become more applicable to real-world medical marijuana decisions.

Researchers could compare different product categories or examine whether patients using different THC-to-CBD ratios report different outcomes. Those findings could then inform more controlled research.

Research Could Help Address Marijuana Safety Questions

Medical marijuana research is not only about identifying potential benefits. It is also important for identifying risks.

Researchers could study potential marijuana interactions with medications, side effects associated with different doses, the effects of long-term use, and whether certain patient populations require additional precautions.

This type of research is particularly important as more patients consider marijuana alongside other treatments. Better safety information could help practitioners have more detailed conversations with patients about both the potential benefits and limitations of medical marijuana.

What Federal Rescheduling Does Not Mean

Changes to federal marijuana policy should not be interpreted as proof that marijuana works for every condition. Medical marijuana research remains a developing field.

Evidence is stronger for certain applications than others, and many questions still require high-quality clinical research.

Federal rescheduling could make conducting that research easier, but scientists still need to do the work necessary to determine which uses are supported by evidence. That is why researchers are calling for dedicated infrastructure.

Could Virginia Play a Larger Role in Marijuana Research?

Virginia has universities, major healthcare systems, medical researchers, and an established medical marijuana program. Those resources could potentially support expanded medical marijuana research if state leaders choose to prioritize it.

A coordinated research initiative could connect patient experiences within Virginia's marijuana program with academic and clinical expertise.

Over time, that could contribute to better guidance for both patients and practitioners.

It could also help Virginia participate in a broader national effort to develop evidence-based standards surrounding medical marijuana.

The Future of Medical Marijuana May Depend on Better Research

Medical marijuana policy in the United States has often moved faster than medical marijuana research. Federal policy changes could create an opportunity to begin closing that gap.

State-led marijuana research centers represent one possible approach. By studying medical marijuana within functioning state programs, researchers may be able to answer questions that patients and practitioners have been asking for years.

Which products work best for particular symptoms? How should patients approach dosing? What are the long-term effects? Which patients are most likely to benefit? Who may face greater risks?

Better research will not necessarily produce simple answers to every question. But it could give practitioners and patients significantly more evidence to work with.

How to Get a Virginia Medical Marijuana Certification

Virginia residents interested in medical marijuana must receive a written certification from an eligible healthcare practitioner.

Virginia no longer requires patients to obtain a separate registration card from the Board of Pharmacy before purchasing medical marijuana. A valid written certification and required identification allow qualifying patients to access Virginia's medical marijuana system.

Virginia Marijuana Card helps patients connect with knowledgeable marijuana doctors who can review their condition and determine whether medical marijuana may be appropriate.

As marijuana research expands, Virginia patients may eventually have access to more detailed evidence regarding marijuana products, dosing, safety, and potential benefits.

Until then, working with an eligible doctor remains an important part of making an informed decision about medical marijuana.

Get Your Virginia Medical Marijuana Card

Although recreational possession is legal in Virginia, a medical marijuana card continues to provide valuable benefits for qualifying patients, including access to licensed medical dispensaries and a selection of regulated marijuana products, and medical guidance from certified medical marijuana doctors.

Getting started is simple. At Virginia Marijuana Card, you can schedule an appointment with one of our experienced medical marijuana doctors through a convenient telemedicine visit. During your appointment, our licensed marijuana doctors will review your symptoms and medical history to determine whether you qualify under Virginia’s medical marijuana program.

If you do, we’ll issue your written certification and walk you through every step of the process so you can begin purchasing medical marijuana legally and confidently. Our team is here to make the experience straightforward, from your initial evaluation to ongoing renewal support, so you always know what to expect.

Schedule an evaluation online today, and we’ll make an appointment for you with one of our knowledgeable, compassionate doctors.

---

Doctors Who Care.

Relief You Can Trust.

At Virginia Marijuana Card, we’re here to make the process easy and stress-free. Our team is dedicated to helping you unlock the full benefits of Virginia’s medical marijuana program while improving your overall quality of life.

Don’t wait to start feeling better. Call us at (888) 633-5808 or schedule your evaluation today

For more blogs like this, plus patient resources and state updates, sign up for our newsletter!